Genitourinary Cancers by Siamak DaneshmandGenitourinary Cancers by Siamak Daneshmand

Genitourinary Cancers

bySiamak DaneshmandEditorKevin G. Chan

Hardcover | September 14, 2018

Pricing and Purchase Info

$161.60 online 
$212.95 list price save 24%
Earn 808 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


This book addresses the most pressing current questions in the management of urologic malignancies. The rapid advances in imaging and molecular markers are placed into a clinical context, with explanation of their effects on prognosis and treatment planning. Similarly, progress in immunotherapy is carefully examined, focusing in particular on the role of immune checkpoint inhibitors in both early- and late-stage urologic malignancies. Looking beyond the improvements in minimally invasive techniques for urologic cancers, the impacts of care coordination pathways and enhanced recovery after surgery protocols are reviewed. Readers will also find enlightening discussion of the decision algorithm for the treatment of early-stage, high-grade bladder cancer, taking into account evidence on the most advanced treatment options and the circumstances in which surgery may need to be expedited. The penultimate chapter discusses the Cancer Genome Atlas project for bladder cancer, and the book closes by considering contemporary medical and surgical management of testicular cancer.

Dr. Sia Daneshmand earned his medical degree at the University of California, Davis and completed his residency at the University of Southern California (USC) followed by a two-year fellowship in Urologic Oncology at the USC/Norris Comprehensive Cancer Center. He spent almost 6 years at Oregon Health and Science University and was then...
Title:Genitourinary CancersFormat:HardcoverDimensions:308 pagesPublished:September 14, 2018Publisher:Springer NatureLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3319933388

ISBN - 13:9783319933382


Table of Contents

New Imaging Techniques in Prostate Cancer.- Targeted ablative therapies for prostate cancer.-  Prostate cancer markers.-  Prognostic value of CTC's in urologic cancers.- Management of Small Renal Masses.-  Advances in the Treatment of Metastatic Renal Cell Carcinoma.-Imaging in urologic cancers .-   Molecular prognostication in Bladder cancer.-  Early cystectomy for high risk non-muscle invasive disease.-  Care-coordination pathway after radical cystectomy.-  Current role of checkpoint inhibitors in urologic cancers.- ) The Cancer Genome Atlas Project.-  Prognostic models in germ cell tumors.- Modern management of testicular cancer.